NAD Recommends Olly Discontinue or Modify Certain Claims for its Kids Chillax Product; Olly to Appeal
At issue for the National Advertising Division (NAD) was whether a clinical study commissioned by Olly on its Chillax product, along with the existing research on L-theanine, supports Olly’s claims.










